166 related articles for article (PubMed ID: 9343216)
1. Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.
Margolin DH; Reimann KA; Sodroski J; Karlsson GB; Tenner-Racz K; Racz P; Letvin NL
J Virol; 1997 Nov; 71(11):8582-91. PubMed ID: 9343216
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.
Chen ZW; Kou ZC; Lekutis C; Shen L; Zhou D; Halloran M; Li J; Sodroski J; Lee-Parritz D; Letvin NL
J Exp Med; 1995 Jul; 182(1):21-31. PubMed ID: 7540651
[TBL] [Abstract][Full Text] [Related]
3. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Letvin NL
J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
[TBL] [Abstract][Full Text] [Related]
4. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
[TBL] [Abstract][Full Text] [Related]
5. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.
Reimann KA; Li JT; Veazey R; Halloran M; Park IW; Karlsson GB; Sodroski J; Letvin NL
J Virol; 1996 Oct; 70(10):6922-8. PubMed ID: 8794335
[TBL] [Abstract][Full Text] [Related]
6. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
Müller S; Margolin DH; Min G
Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
[TBL] [Abstract][Full Text] [Related]
7. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
8. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
[TBL] [Abstract][Full Text] [Related]
9. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
Liao HX; Etemad-Moghadam B; Montefiori DC; Sun Y; Sodroski J; Scearce RM; Doms RW; Thomasch JR; Robinson S; Letvin NL; Haynes BF
J Virol; 2000 Jan; 74(1):254-63. PubMed ID: 10590113
[TBL] [Abstract][Full Text] [Related]
12. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).
Cayabyab M; Karlsson GB; Etemad-Moghadam BA; Hofmann W; Steenbeke T; Halloran M; Fanton JW; Axthelm MK; Letvin NL; Sodroski JG
J Virol; 1999 Feb; 73(2):976-84. PubMed ID: 9882298
[TBL] [Abstract][Full Text] [Related]
13. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
14. Utility of SHIV for testing HIV-1 vaccine candidates in macaques.
Lu Y; Salvato MS; Pauza CD; Li J; Sodroski J; Manson K; Wyand M; Letvin N; Jenkins S; Touzjian N; Chutkowski C; Kushner N; LeFaile M; Payne LG; Roberts B
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):99-106. PubMed ID: 8680896
[TBL] [Abstract][Full Text] [Related]
15. High frequency of virus-specific B lymphocytes in germinal centers of simian-human immunodeficiency virus-infected rhesus monkeys.
Margolin DH; Saunders EF; Bronfin B; de Rosa N; Axthelm MK; Alvarez X; Letvin NL
J Virol; 2002 Apr; 76(8):3965-73. PubMed ID: 11907236
[TBL] [Abstract][Full Text] [Related]
16. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
[TBL] [Abstract][Full Text] [Related]
17. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
18. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.
Reimann KA; Li JT; Voss G; Lekutis C; Tenner-Racz K; Racz P; Lin W; Montefiori DC; Lee-Parritz DE; Lu Y; Collman RG; Sodroski J; Letvin NL
J Virol; 1996 May; 70(5):3198-206. PubMed ID: 8627800
[TBL] [Abstract][Full Text] [Related]
19. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
Klinger JM; Himathongkham S; Legg H; Luciw PA; Barnett SW
AIDS; 1998 May; 12(8):849-57. PubMed ID: 9631137
[TBL] [Abstract][Full Text] [Related]
20. CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype.
Mao H; Lafont BA; Igarashi T; Nishimura Y; Brown C; Hirsch V; Buckler-White A; Sadjadpour R; Martin MA
J Virol; 2005 Dec; 79(23):14887-98. PubMed ID: 16282488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
